Please login to the form below

Not currently logged in
Email:
Password:

Peter Kelly named managing director of Accord Healthcare UK

He was previously commercial director at Actavis UK

Peter Kelly Accord Healthcare ActavisAccord Healthcare has appointed Peter Kelly as its UK managing director, a move that sees him transition from Actavis, whose UK and Ireland operations Accord acquired last year.

Kelly spent 12 years at Actavis, most recently as commercial director. The Actavis Generics business was acquired from Allergan in 2016 by Teva, which then sold a chunk of it to Accord Healthcare, a subsidiary of Indian generics firm Intas Pharmaceuticals.

Kelly said: “Accord Healthcare is one of the fastest growing generic pharmaceutical companies in the UK, with us supplying one in six of the UK’s generic medicines. We remain committed to R&D and bringing cost competitive new products to market at the earliest opportunity.

“This is an exciting opportunity to lead our teams of brilliant people who continue to focus on excellent service, allowing us to work in partnership with customers as their Partner of Choice.”

Meanwhile, former Actavis UK managing director Jonathan Wilson has been appointed vice president, West Europe at Accord Healthcare.

He spent three years heading up Actavis’ UK operations and before that help senior commercial roles at Sandoz and Novartis.

11th July 2017

From: Sales

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
dna Communications

Healthcare communications with unique thinking, insight and attitude...

Latest intelligence

What does the future hold for Light-chain Amyloidosis?
Recent advances in the understanding and treatment are reforming pharma’s approach to the management of this rare disease. With a new standard of care rapidly developing, what does the landscape...
Webinar:
Securing a future for telehealth with immersive market research insights...
Accelerating patient recruitment in clinical trials with the Clinical Enrolment Managers (CEMs)
How Innovative Trials' global Clinical Enrolment Managers (CEMs) give clinical trial sites the local touch...